News

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...
The rolls were sold at the retail level in Pennsylvania, California, Connecticut, Maryland, Delaware, and Ohio, according to ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...
Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...
The US Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to ...
Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.